vs

Side-by-side financial comparison of Brown & Brown (BRO) and Xylem Inc. (XYL). Click either name above to swap in a different company.

Xylem Inc. is the larger business by last-quarter revenue ($2.1B vs $1.6B, roughly 1.3× Brown & Brown). Brown & Brown runs the higher net margin — 16.5% vs 8.9%, a 7.6% gap on every dollar of revenue. On growth, Brown & Brown posted the faster year-over-year revenue change (35.8% vs 2.7%). Over the past eight quarters, Brown & Brown's revenue compounded faster (13.0% CAGR vs -1.0%).

Brown & Brown, Inc. is an American insurance brokerage firm headquartered in Daytona Beach, Florida. It is one of the largest independent insurance intermediaries in the United States, providing risk management solutions, insurance products, and services to businesses, governmental institutions, professional organizations, trade associations, and individuals.

Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.

BRO vs XYL — Head-to-Head

Bigger by revenue
XYL
XYL
1.3× larger
XYL
$2.1B
$1.6B
BRO
Growing faster (revenue YoY)
BRO
BRO
+33.1% gap
BRO
35.8%
2.7%
XYL
Higher net margin
BRO
BRO
7.6% more per $
BRO
16.5%
8.9%
XYL
Faster 2-yr revenue CAGR
BRO
BRO
Annualised
BRO
13.0%
-1.0%
XYL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BRO
BRO
XYL
XYL
Revenue
$1.6B
$2.1B
Net Profit
$265.0M
$189.0M
Gross Margin
37.8%
Operating Margin
11.5%
Net Margin
16.5%
8.9%
Revenue YoY
35.8%
2.7%
Net Profit YoY
26.8%
13.2%
EPS (diluted)
$0.55
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRO
BRO
XYL
XYL
Q1 26
$2.1B
Q4 25
$1.6B
$2.4B
Q3 25
$1.6B
$2.3B
Q2 25
$1.3B
$2.3B
Q1 25
$1.4B
$2.1B
Q4 24
$1.2B
$2.3B
Q3 24
$1.2B
$2.1B
Q2 24
$1.2B
$2.2B
Net Profit
BRO
BRO
XYL
XYL
Q1 26
$189.0M
Q4 25
$265.0M
$335.0M
Q3 25
$227.0M
$227.0M
Q2 25
$231.0M
$226.0M
Q1 25
$331.0M
$169.0M
Q4 24
$209.0M
$326.0M
Q3 24
$234.0M
$217.0M
Q2 24
$257.0M
$194.0M
Gross Margin
BRO
BRO
XYL
XYL
Q1 26
37.8%
Q4 25
38.9%
Q3 25
38.9%
Q2 25
38.8%
Q1 25
37.1%
Q4 24
38.0%
Q3 24
37.3%
Q2 24
37.8%
Operating Margin
BRO
BRO
XYL
XYL
Q1 26
11.5%
Q4 25
14.7%
Q3 25
14.7%
Q2 25
13.3%
Q1 25
11.2%
Q4 24
23.3%
11.8%
Q3 24
26.7%
13.3%
Q2 24
29.4%
11.7%
Net Margin
BRO
BRO
XYL
XYL
Q1 26
8.9%
Q4 25
16.5%
14.0%
Q3 25
14.1%
10.0%
Q2 25
18.0%
9.8%
Q1 25
23.6%
8.2%
Q4 24
17.7%
14.5%
Q3 24
19.7%
10.3%
Q2 24
21.8%
8.9%
EPS (diluted)
BRO
BRO
XYL
XYL
Q1 26
$0.79
Q4 25
$0.55
$1.37
Q3 25
$0.68
$0.93
Q2 25
$0.78
$0.93
Q1 25
$1.15
$0.69
Q4 24
$0.73
$1.33
Q3 24
$0.81
$0.89
Q2 24
$0.90
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRO
BRO
XYL
XYL
Cash + ST InvestmentsLiquidity on hand
$1.1B
$808.0M
Total DebtLower is stronger
$7.6B
$1.9B
Stockholders' EquityBook value
$12.6B
$11.0B
Total Assets
$30.0B
$17.0B
Debt / EquityLower = less leverage
0.61×
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRO
BRO
XYL
XYL
Q1 26
$808.0M
Q4 25
$1.1B
$1.5B
Q3 25
$1.2B
$1.2B
Q2 25
$8.9B
$1.2B
Q1 25
$669.0M
$1.1B
Q4 24
$685.0M
$1.1B
Q3 24
$968.0M
$989.0M
Q2 24
$1.1B
$815.0M
Total Debt
BRO
BRO
XYL
XYL
Q1 26
$1.9B
Q4 25
$7.6B
$2.0B
Q3 25
$7.7B
$2.0B
Q2 25
$7.5B
$2.0B
Q1 25
$3.8B
$2.0B
Q4 24
$3.8B
$2.0B
Q3 24
$3.6B
Q2 24
$4.1B
Stockholders' Equity
BRO
BRO
XYL
XYL
Q1 26
$11.0B
Q4 25
$12.6B
$11.5B
Q3 25
$12.4B
$11.2B
Q2 25
$11.6B
$11.1B
Q1 25
$6.8B
$10.8B
Q4 24
$6.4B
$10.6B
Q3 24
$6.5B
$10.6B
Q2 24
$6.0B
$10.3B
Total Assets
BRO
BRO
XYL
XYL
Q1 26
$17.0B
Q4 25
$30.0B
$17.6B
Q3 25
$29.4B
$17.3B
Q2 25
$25.6B
$17.2B
Q1 25
$16.8B
$16.6B
Q4 24
$17.6B
$16.5B
Q3 24
$17.5B
$16.0B
Q2 24
$15.9B
$15.8B
Debt / Equity
BRO
BRO
XYL
XYL
Q1 26
0.18×
Q4 25
0.61×
0.17×
Q3 25
0.62×
0.18×
Q2 25
0.65×
0.18×
Q1 25
0.56×
0.19×
Q4 24
0.59×
0.19×
Q3 24
0.55×
Q2 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRO
BRO
XYL
XYL
Operating Cash FlowLast quarter
$444.0M
Free Cash FlowOCF − Capex
$424.0M
FCF MarginFCF / Revenue
26.4%
Capex IntensityCapex / Revenue
1.2%
4.2%
Cash ConversionOCF / Net Profit
1.68×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRO
BRO
XYL
XYL
Q1 26
Q4 25
$444.0M
$543.0M
Q3 25
$468.0M
$360.0M
Q2 25
$325.0M
$305.0M
Q1 25
$213.0M
$33.0M
Q4 24
$361.0M
$575.0M
Q3 24
$440.0M
$311.0M
Q2 24
$360.0M
$288.0M
Free Cash Flow
BRO
BRO
XYL
XYL
Q1 26
Q4 25
$424.0M
$460.0M
Q3 25
$452.0M
$281.0M
Q2 25
$310.0M
$207.0M
Q1 25
$196.0M
$-38.0M
Q4 24
$341.0M
$475.0M
Q3 24
$417.0M
$237.0M
Q2 24
$334.0M
$215.0M
FCF Margin
BRO
BRO
XYL
XYL
Q1 26
Q4 25
26.4%
19.2%
Q3 25
28.1%
12.4%
Q2 25
24.1%
9.0%
Q1 25
14.0%
-1.8%
Q4 24
28.8%
21.1%
Q3 24
35.2%
11.3%
Q2 24
28.4%
9.9%
Capex Intensity
BRO
BRO
XYL
XYL
Q1 26
4.2%
Q4 25
1.2%
3.5%
Q3 25
1.0%
3.5%
Q2 25
1.2%
4.3%
Q1 25
1.2%
3.4%
Q4 24
1.7%
4.4%
Q3 24
1.9%
3.5%
Q2 24
2.2%
3.4%
Cash Conversion
BRO
BRO
XYL
XYL
Q1 26
Q4 25
1.68×
1.62×
Q3 25
2.06×
1.59×
Q2 25
1.41×
1.35×
Q1 25
0.64×
0.20×
Q4 24
1.73×
1.76×
Q3 24
1.88×
1.43×
Q2 24
1.40×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRO
BRO

US$1.4B87%
GB$147.0M9%
Profit Sharing Contingent Commission Revenue$33.0M2%
Other Supplemental Commissions Revenue$25.0M2%

XYL
XYL

Revenue from products$1.8B83%
Revenue from services$368.0M17%

Related Comparisons